Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-15 Soffer Gad EVP & Chief Strategy Officer Exercise or conversion · Restricted Stock Units −4,146 11,055
2017-05-10 Porter Derrell SVP, Head of Global Commercial Grant or award · Employee Stock Option (Right to Buy) +130,000 130,000
2017-04-26 Ciechanover Isaac E. Chief Executive Officer Sale −3,600 $17.78 $64K 467,778
2017-04-25 Ciechanover Isaac E. Chief Executive Officer Sale −2,100 $17.07 $36K 472,878
2017-04-25 Ciechanover Isaac E. Chief Executive Officer Sale −1,500 $17.70 $27K 471,378
2017-04-17 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,000 $17.28 $104K 380,855
2017-04-11 Ciechanover Isaac E. Chief Executive Officer Sale −4,200 $16.99 $71K 474,978
2017-04-10 Ciechanover Isaac E. Chief Executive Officer Sale −3,000 $17.08 $51K 479,178
2017-04-03 Newell Joe Chief Tech. Operations Officer Grant or award +7,500 7,500
2017-04-03 Newell Joe Chief Tech. Operations Officer Grant or award · Employee Stock Option (Right to Buy) +90,000 90,000
2017-03-28 Ciechanover Isaac E. Chief Executive Officer Sale −3,182 $18.99 $60K 482,596
2017-03-28 Ciechanover Isaac E. Chief Executive Officer Sale −418 $19.86 $8K 482,178
2017-03-27 Ciechanover Isaac E. Chief Executive Officer Sale −12,400 $20.34 $252K 485,778
2017-03-23 MCGRATH JOHN EVP & Chief Financial Officer Sale −6,500 $21.08 $137K 112,827
2017-03-22 MCGRATH JOHN EVP & Chief Financial Officer Sale −7,500 $20.27 $152K 119,327
2017-03-17 Ciechanover Isaac E. Chief Executive Officer Sale −2,400 $18.50 $44K 515,778
2017-03-17 Ciechanover Isaac E. Chief Executive Officer Sale −17,600 $20.01 $352K 498,178
2017-03-16 Ciechanover Isaac E. Chief Executive Officer Sale −10,800 $18.54 $200K 518,178
2017-03-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,000 $19.60 $118K 386,855
2017-03-10 Soffer Gad EVP & Chief Strategy Officer Sale −2,500 $20.00 $50K 266,527

Page 45 of 71 · 1,403 trades